Singapore leads SEA health tech and life sciences funding in 2024

Singapore raised a total of $92.4m in 2024.

Singapore led Southeast Asia in healthtech and life sciences funding in 2024, raising $92.4m across 14 rounds, Traxcn reported.

Jakarta followed at a distant second with $9m raised, whilst Kuala Lumpur comes next with $592,000.

The top funding rounds were also from Singapore, with HealthifyMe raising $20m in Series C, Biobot Surgical securing $17.9m in Series B, and Allozymes obtaining $15m in Series A.

Singapore’s Mistletoe ranked fourth amongst the most active accelerators and incubators, whilst Cocoon Capital placed fourth for VC seed, ZIG Ventures fifth for VC early stage, and Marubeni second for private equity.

Follow the link for more news on

Chart of the Day

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia